Preoperative pembrolizumab‑induced hemophagocytic lymphohistiocytosis in a patient with breast cancer: A case report

Recently, the anti-programmed cell death protein 1 antibody pembrolizumab, a type of immune checkpoint inhibitor (ICI), has been used in preoperative systemic chemotherapy for hormone receptor and human epidermal growth factor 2-negative breast cancer, also known as triple-negative breast cancer (TN...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2025-03, Vol.29 (3), p.136, Article 136
Hauptverfasser:	Kawamura, Yukino, Shimomura, Akihiko, Taniyama, Tomoko, Hirai, Hoshie, Hashimoto, Kazuki, Honda, Yayoi, Kitagawa, Dai, Nasu, Ryo, Shimazu, Hiroshi, Hangaishi, Akira, Shimizu, Chikako
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune diseases Biopsy Breast cancer Cancer therapies Case Report Case reports Chemotherapy Colonoscopy Coronaviruses COVID-19 Cytokine storm Diarrhea Epstein-Barr virus Fever Hepatitis Hospitalization Immune system Infections Infectious diseases Inflammatory bowel disease Liver Medical prognosis Mortality Pathogenesis Patients Steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!